TITLE

Challenges in the clinical application of induced pluripotent stem cells

AUTHOR(S)
Sipp, Douglas
PUB. DATE
January 2010
SOURCE
Stem Cell Research & Therapy;2010, Vol. 1 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The advent of human induced pluripotent stem cells has been heralded as a major breakthrough in the study of pluripotent stem cells, for these cells have yielded fundamental insights into the reprogrammability of somatic cell fates, but also because of their seemingly great promise in applications, including potential uses in cell therapy. Several recent reports in the scientific literature and mass media, however, have challenged this concept for reasons of biological function and business feasibility, presenting an important opportunity to re-examine the prospects for human induced pluripotent stem cells in medicine. In this commentary, I will outline a number of hurdles that will need to be cleared if these cells are to fulfil their clinical promise, and suggest avenues that might facilitate these important endeavours.
ACCESSION #
90377697

 

Related Articles

  • Tbx3: another important piece fitted into the pluripotent stem cell puzzle. Pirity, Melinda K.; Dinnyes, Andras // Stem Cell Research & Therapy;2010, Vol. 1 Issue 2, p1 

    Induced pluripotent stem cells (iPSCs) are novel tools for biomedical research, with a promise for future regenerative medicine applications. Recently, Han and colleagues reported in Nature that T box gene 3 (Tbx3) can improve the quality of mouse iPSCs and increase their germline transmission...

  • Corrigendum: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Lister, Ryan; Pelizzola, Mattia; Kida, Yasuyuki S.; Hawkins, R. David; Nery, Joseph R.; Hon, Gary; Antosiewicz-Bourget, Jessica; O'Malley, Ronan; Castanon, Rosa; Klugman, Sarit; Downes, Michael; Yu, Ruth; Stewart, Ron; Ren, Bing; Thomson, James A.; Evans, Ronald M.; Ecker, Joseph R. // Nature;10/2/2014, Vol. 514 Issue 7520, p126 

    A correction to the article "Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cell" that was published in the March 03, 2011 issue is presented

  • Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells. Shipony, Zohar; Mukamel, Zohar; Cohen, Netta Mendelson; Landan, Gilad; Tanay, Amos; Chomsky, Elad; Zeliger, Shlomit Reich; Friedman, Nir; Fried, Yael Chagit; Ainbinder, Elena // Nature;9/4/2014, Vol. 513 Issue 7516, p115 

    Stable maintenance of gene regulatory programs is essential for normal function in multicellular organisms. Epigenetic mechanisms, and DNA methylation in particular, are hypothesized to facilitate such maintenance by creating cellular memory that can be written during embryonic development and...

  • In Vitro Modeling of Paraxial Mesodermal Progenitors Derived from Induced Pluripotent Stem Cells. Sakurai, Hidetoshi; Sakaguchi, Yasuko; Shoji, Emi; Nishino, Tokiko; Maki, Izumi; Sakai, Hiroshi; Hanaoka, Kazunori; Kakizuka, Akira; Sehara-Fujisawa, Atsuko // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Induced pluripotent stem (iPS) cells are generated from adult somatic cells by transduction of defined factors. Given their unlimited proliferation and differentiation potential, iPS cells represent promising sources for cell therapy and tools for research and drug discovery. However, systems...

  • Deterministic direct reprogramming of somatic cells to pluripotency. Rais, Yoach; Zviran, Asaf; Geula, Shay; Gafni, Ohad; Chomsky, Elad; Viukov, Sergey; Mansour, Abed AlFatah; Caspi, Inbal; Krupalnik, Vladislav; Zerbib, Mirie; Maza, Itay; Mor, Nofar; Baran, Dror; Weinberger, Leehee; Jaitin, Diego A.; Lara-Astiaso, David; Blecher-Gonen, Ronnie; Shipony, Zohar; Mukamel, Zohar; Hagai, Tzachi // Nature;10/3/2013, Vol. 502 Issue 7469, p65 

    Somatic cells can be inefficiently and stochastically reprogrammed into induced pluripotent stem (iPS) cells by exogenous expression of Oct4 (also called Pou5f1), Sox2, Klf4 and Myc (hereafter referred to as OSKM). The nature of the predominant rate-limiting barrier(s) preventing the majority of...

  • Advances in Induced Pluripotent Stem Cell Technologies. Pal, Rajarshi; Rao, Mahendra; Vemuri, Mohan C.; Verma, Paul; Dinnyes, Andras // Stem Cells International;2012, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the technological advancements in the field of induced pluripotent stem cells (iPSC).

  • What is the point of large-scale collections of human induced pluripotent stem cells? McKernan, Ruth; Watt, Fiona M // Nature Biotechnology;Oct2013, Vol. 31 Issue 10, p875 

    A letter to the editor is presented related to the study "What is the point of large-scale collections of human induced pluripotent stem cells" by Ruth McKernan and Fiona M Watt in October 2013 issue.

  • Get your spares at the organ farm. Slezak, Michael // New Scientist;6/29/2013, Vol. 218 Issue 2923, p6 

    The article discusses human-animal chimera research by biologist Hiromitsu Nakauchi and team using human stem cells in pigs in order to produce human organs for transplantation. The approach uses human induced pluripotent stem (iPS) cells, which are injected into an swine blastocyst from a line...

  • Stem cells: Efficient reprogramming from a privileged cell state.  // Nature Methods;Apr2014, Vol. 11 Issue 4, p369 

    The article discusses a research conducted by S. Guo, related to the identification of mouse granulocyte-monocyte progenitors and embryonic fibroblasts for reprogramming of somatic cells to induced pluripotency, published in a 2014 issue of the periodical "Cell."

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics